These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24136390)

  • 1. Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.
    Oka S; Okudaira H; Ono M; Schuster DM; Goodman MM; Kawai K; Shirakami Y
    Mol Imaging Biol; 2014 Jun; 16(3):322-9. PubMed ID: 24136390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.
    Ono M; Oka S; Okudaira H; Schuster DM; Goodman MM; Kawai K; Shirakami Y
    Brain Res; 2013 Oct; 1535():24-37. PubMed ID: 23994214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
    Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K
    Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer.
    Okudaira H; Shikano N; Nishii R; Miyagi T; Yoshimoto M; Kobayashi M; Ohe K; Nakanishi T; Tamai I; Namiki M; Kawai K
    J Nucl Med; 2011 May; 52(5):822-9. PubMed ID: 21536930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid (anti-[18F]FACBC) accumulation in lymph node prostate cancer metastasis and lymphadenitis in rats.
    Kanagawa M; Doi Y; Oka S; Kobayashi R; Nakata N; Toyama M; Shirakami Y
    Nucl Med Biol; 2014 Aug; 41(7):545-51. PubMed ID: 24816330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings.
    Doi Y; Kanagawa M; Maya Y; Tanaka A; Oka S; Nakata N; Toyama M; Matsumoto H; Shirakami Y
    Nucl Med Biol; 2015 Aug; 42(8):664-72. PubMed ID: 26022202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters.
    Okudaira H; Oka S; Ono M; Nakanishi T; Schuster DM; Kobayashi M; Goodman MM; Tamai I; Kawai K; Shirakami Y
    Mol Imaging Biol; 2014 Dec; 16(6):756-64. PubMed ID: 24943499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells.
    Oka S; Okudaira H; Yoshida Y; Schuster DM; Goodman MM; Shirakami Y
    Nucl Med Biol; 2012 Jan; 39(1):109-19. PubMed ID: 21958853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer.
    Oka S; Hattori R; Kurosaki F; Toyama M; Williams LA; Yu W; Votaw JR; Yoshida Y; Goodman MM; Ito O
    J Nucl Med; 2007 Jan; 48(1):46-55. PubMed ID: 17204698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of anti-1-amino-2-[18F]fluoro-cyclobutyl-1-carboxylic acid (anti-2-[18F]FACBC) in rat 9L gliosarcoma.
    Yu W; Williams L; Camp VM; Olson JJ; Goodman MM
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2140-3. PubMed ID: 20207538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2.
    Okudaira H; Nakanishi T; Oka S; Kobayashi M; Tamagami H; Schuster DM; Goodman MM; Shirakami Y; Tamai I; Kawai K
    Nucl Med Biol; 2013 Jul; 40(5):670-5. PubMed ID: 23647854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells.
    Ono M; Oka S; Okudaira H; Nakanishi T; Mizokami A; Kobayashi M; Schuster DM; Goodman MM; Shirakami Y; Kawai K
    Nucl Med Biol; 2015 Nov; 42(11):887-92. PubMed ID: 26278491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions.
    Amzat R; Taleghani P; Miller DL; Beitler JJ; Bellamy LM; Nye JA; Yu W; Savir-Baruch B; Osunkoya AO; Chen Z; Auffermann WF; Goodman MM; Schuster DM
    Mol Imaging Biol; 2013 Oct; 15(5):633-43. PubMed ID: 23595643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of
    Gusman M; Aminsharifi JA; Peacock JG; Anderson SB; Clemenshaw MN; Banks KP
    Radiographics; 2019; 39(3):822-841. PubMed ID: 31059396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
    Ishiwata K; Takahashi T; Iwata R; Tomura M; Tada M; Itoh J; Kameyama M; Ido T
    Int J Rad Appl Instrum B; 1992 Aug; 19(6):611-8. PubMed ID: 1387872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Brain Tumors Using Amino Acid Transport PET Imaging with
    Tsuyuguchi N; Terakawa Y; Uda T; Nakajo K; Kanemura Y
    Asia Ocean J Nucl Med Biol; 2017; 5(2):85-94. PubMed ID: 28660218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors.
    Shoup TM; Olson J; Hoffman JM; Votaw J; Eshima D; Eshima L; Camp VM; Stabin M; Votaw D; Goodman MM
    J Nucl Med; 1999 Feb; 40(2):331-8. PubMed ID: 10025843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    Nanni C; Zanoni L; Pultrone C; Schiavina R; Brunocilla E; Lodi F; Malizia C; Ferrari M; Rigatti P; Fonti C; Martorana G; Fanti S
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1601-10. PubMed ID: 26960562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
    Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
    J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.